Compare GBDC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBDC | AMRX |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 2010 | N/A |
| Metric | GBDC | AMRX |
|---|---|---|
| Price | $13.57 | $12.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $14.83 | $13.25 |
| AVG Volume (30 Days) | ★ 2.0M | 1.8M |
| Earning Date | 02-03-2026 | 10-30-2025 |
| Dividend Yield | ★ 11.50% | N/A |
| EPS Growth | ★ 4.09 | N/A |
| EPS | ★ 1.42 | 0.02 |
| Revenue | $870,777,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | N/A | $9.99 |
| Revenue Next Year | N/A | $6.67 |
| P/E Ratio | ★ $9.58 | $671.35 |
| Revenue Growth | ★ 20.16 | 9.50 |
| 52 Week Low | $12.68 | $6.69 |
| 52 Week High | $16.01 | $13.01 |
| Indicator | GBDC | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.32 | 58.74 |
| Support Level | $13.44 | $12.81 |
| Resistance Level | $13.65 | $12.99 |
| Average True Range (ATR) | 0.20 | 0.25 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 24.77 | 62.36 |
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.